National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
NHI Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
National Health Investors, Inc.NYSE: NHI
Gross Profit · Q3 FY2026 · quarter ended Sep 2026
Gross profit declines year over year
Q3 FY2026 gross profit of $74.55M fell 14.5% year over year, ahead of the -32.8% change in trailing-twelve-month gross profit. Sequentially, it fell 12.1% from the prior quarter. Over 3 fiscal years it compounded at -19.7% a year.
Context
- Gross profit amounted to 36.7% of revenue in FY2025, down 60.0 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -14.5% holds above the trailing-twelve-month pace of -32.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 138.93M USD
- Year-over-year change
- -57.1%
- 4-year CAGR
- -16.6%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 138.93M | -57.1% |
| FY2024 | 2024-12-31 | 324.02M | +5.1% |
| FY2023 | 2023-12-31 | 308.32M | +14.9% |
| FY2022 | 2022-12-31 | 268.41M | -6.5% |
| FY2021 | 2021-12-31 | 287.08M | — |
Gross Profit vs competitors
How NHI compares with its peers on the latest reported figures
- NHI's LTM Sep 2026 gross profit of $231.21M is the 8th highest of the 9 companies compared; the peer median is $539.49M.
- Its year-over-year change of -32.8% is the 8th highest of 9, against a peer median of +5.3%.
- Gross profit amounts to 50.6% of revenue for NHI, versus a peer median of 51.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.05B | -12.8% | -27.3% | 60.6% | |
| LTM Sep 2026 | $1.83B | +3.0% | -5.0% | 16.7% | |
| LTM Mar 2026 | $1.12B | +104.7% | +23.9% | 92.6% | |
| LTM Sep 2026 | $547.4M | -69.8% | +25.0% | 29.7% | |
| LTM Jun 2026 | $531.57M | +7.7% | +2.9% | 61.8% | |
| LTM Jun 2026 | $508.64M | -14.8% | -16.7% | 69.6% | |
| LTM Jun 2026 | $295.07M | +9.1% | -18.8% | 37.6% | |
| LTM Sep 2026 | $231.21M | -32.8% | -19.7% | 50.6% | |
| LTM Jun 2026 | $206.48M | +112.6% | +11.7% | 43.2% | |
| Peer median (excluding NHI) | $539.49M | +5.3% | -1.1% | 51.9% | |
Competitors are the stored peer set for NHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 298.72M | 278.19M | 319.84M | 335.18M | 378.53M |
| Cost of Revenue | 11.64M | 9.79M | 11.51M | 11.17M | 239.6M |
| Gross Profit | 287.08M | 268.41M | 308.32M | 324.02M | 138.93M |
| Gross Margin | 96.1% | 96.5% | 96.4% | 96.7% | 36.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.34M | 25.32M | 19.82M | 21.79M | 0 |
| Operating Expenses | 101.83M | 135.64M | 129.53M | 140.16M | (55.9M) |
| Depreciation & Amortization | 80.8M | 70.88M | 69.97M | 71.44M | 83.85M |
| EBITDA | 240.94M | 178.73M | 259.87M | 264.16M | 282M |
| EBITDA Margin | 80.7% | 64.2% | 81.3% | 78.8% | 74.5% |
| Operating Income | 185.25M | 132.77M | 178.79M | 183.86M | 194.83M |
| Operating Margin | 62.0% | 47.7% | 55.9% | 54.9% | 51.5% |
| Interest Income | 0 | 0 | (2.65M) | 0 | 23.82M |
| Interest Expense | 48.11M | 42.44M | 55.51M | 56.12M | 57.37M |
| Other Income / Expenses | (73.22M) | (67.35M) | (44.41M) | (47.26M) | (54.04M) |
| Income Before Tax | 112.03M | 65.41M | 134.38M | 136.59M | 140.79M |
| Pre-Tax Margin | 37.5% | 23.5% | 42.0% | 40.8% | 37.2% |
| Income Tax Expense | 66K | (89K) | 0 | (45K) | 0 |
| Net Income | 111.8M | 66.4M | 135.65M | 137.99M | 142.18M |
| Net Margin | 37.4% | 23.9% | 42.4% | 41.2% | 37.6% |
| EPS (Basic) | 1.36 | 0.52 | 3.13 | 3.14 | 3.03 |
| EPS (Diluted) | 1.36 | 0.51 | 3.13 | 3.13 | 3.02 |
| Weighted Avg Shares | 45.71M | 44.77M | 43.39M | 43.85M | 46.88M |
| Weighted Avg Shares (Diluted) | 45.73M | 44.79M | 43.39M | 44.1M | 47.05M |
National Health Investors, Inc.
NYSE:NHI
Intrinsic Alpha fair value
Locked
Current Price
$62.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.